Skip to main content

DBV Technologies S.A.

DBVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001613780

In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.

Other share classesDBVTF

Q2 2025 vs. Q1 2025

How the institutions holding DBV Technologies S.A. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of DBVT: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders1629+13
Shares2.47M7.23M+4.76M (+193.1%)
Value$16.8M$66.2M+$49.4M (+293.5%)

New holders (16)

Institutions that held DBV Technologies S.A. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to DBVT in Q2 2025
InstitutionSharesValue% of portfolio
Adage Capital Partners GP, L.L.C.1,054,506$9.66M0.02%
Vivo Capital, LLC1,054,506$9.66M0.99%
MPM Oncology Impact Management LP1,054,504$9.65M1.67%
Octagon Capital Advisors LP1,018,021$9.31M2.05%
Great Point Partners LLC374,679$3.43M2.23%
Millennium Management LLC268,014$2.45M0.00%
Nan Fung Trinity (HK) Ltd37,095$339.8K0.04%
MYDA Advisors LLC30,220$276.8K0.08%
Point72 Asset Management, L.P.17,000$155.7K0.00%
Truvestments Capital LLC1,822$16.7K0.00%
Steward Partners Investment Advisory, LLC1,518$13.9K0.00%
Raymond James Financial Inc916$8.39K0.00%
EverSource Wealth Advisors, LLC524$4.80K0.00%
GAMMA Investing LLC346$3.17K0.00%
Trust Co of Toledo NA10$920.00%
Principal Securities, Inc.8$730.00%

Sold out (3)

Institutions that held DBV Technologies S.A. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of DBVT in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Cantor Fitzgerald, L. P.95,460$651.0K
Nan Fung Group Holdings Ltd37,095$253.0K
Toronto Dominion Bank320$2.18K